Insights into cancer drug's lethal side effects aim to enhance safety Anshika Mishra10 Feb 2024 9:30 AM ISTIn a new study, researchers from the University of Illinois Chicago and other universities have identified mechanisms that cause the drug, ponatinib,...
Bariatric surgery most effective for long-term BP control among obese people Dr. Kamal Kant Kohli8 Feb 2024 11:00 AM ISTBariatric surgery is more effective in controlling hypertension rates, or high blood pressure, in people with obesity and uncontrolled high blood...
Both psychotherapy and antidepressants feasible options for managing depression in HF patients: JAMA Medha Baranwal5 Feb 2024 9:30 AM ISTUSA: To ameliorate depression in patients with heart failure, they could be given the choice between antidepressant medication management (MEDS) or...
Novartis Gets CDSCO Panel Nod to Study XXB750 in Patients With Heart Failure Dr. Divya Colin2 Feb 2024 6:00 PM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Dapagliflozin therapy helps reduce CV mortality in heart failure with improved ejection fraction: JAMA Medha Baranwal1 Feb 2024 11:00 AM ISTUSA: Adding a sodium-glucose transport protein 2 inhibitor therapy to other guideline-directed medical therapies may help lower cardiovascular...
Multi-arterial CABG tied to superior long-term survival compared to single arterial grafting Dr. Kamal Kant Kohli31 Jan 2024 10:00 AM ISTUSA: A recent study has found that multi-arterial grafting CABG is associated with superior long-term survival compared to single arterial grafting,...
Almost 50% of patients under 60 years choose TAVR over SAVR with worse outcomes Prem Aggarwal30 Jan 2024 1:45 AM ISTDespite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under age 65 with severe aortic stenosis, many...
Novo Nordisk Gets CDSCO Panel Nod to Study Ziltivekimab Dr. Divya Colin25 Jan 2024 6:00 PM ISTNew Delhi: The drug major Novo Nordisk has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sun Pharma gets non-exclusive rights to market second brand of Finerenone in India Ruchika Sharma19 Jan 2024 11:17 AM ISTBayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa.
In HF patients, intravenous iron reduces both CV death and HF-related events Jacinthlyn Sylvia17 Jan 2024 10:00 AM ISTA recent study published in the JACC: Heart Failure analyzed the guidelines that advocate the consideration of intravenous iron to reduce heart...
Carvedilol fails to prevent heart failure in anthracycline-exposed survivors of childhood cancer: PREVENT-HF trial Medha Baranwal16 Jan 2024 3:30 AM ISTUSA: A randomised, controlled, phase 2b trial (PREVENT-HF) has shed light on the effect of carvedilol versus placebo on cardiac function in...
Bayer's AskBio begins Phase II GenePHIT trial in Congestive Heart Failure Ruchika Sharma14 Jan 2024 11:30 AM ISTBerlin: Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer...
